Literature DB >> 32876043

Effects of obstructive sleep apnea on the thoracic aorta and the main pulmonary artery: assessment by CT.

Roberto Castellana1, Giacomo Aringhieri1, Luna Gargani2, Michelangelo Maestri3, Alessandro Schirru3, Enrica Bonanni3, Ugo Faraguna4,5.   

Abstract

STUDY
OBJECTIVES: The influence of obstructive sleep apnea (OSA) on thoracic aortic size is debated. We aimed to identify possible relations between sleep parameters and the sizes of the ascending aorta (AA), the descending thoracic aorta (DTA), and the main pulmonary artery (MPA) in patients with untreated OSA and in a subgroup of participants without comorbidities capable of affecting the size of great thoracic vessels.
METHODS: We retrospectively measured AA, DTA, and MPA sizes on the chest computed tomography scans of 60 patients with OSA who underwent sleep studies within 1 year before or after the computed tomography. Univariate and multivariate analyses were performed on all patient findings, while an additional univariate analysis was conducted on the data for 22 participants without comorbidities. The latter had been divided into subgroups depending on the sleep parameters, and comparisons were made between them.
RESULTS: The logarithm of the time of oxygen saturation below 90% (CT90) significantly predicted AA and MPA sizes in all patients with OSA (P < .05). Oxygen desaturation index and minimum oxygen saturation were moderately correlated with AA and DTA sizes in patients without comorbidities (P < .01). In this group, subjects with oxygen desaturation index > 30 or minimum oxygen saturation < 81% had greater AA and DTA dimensions (P < .05).
CONCLUSIONS: In patients with OSA, time of oxygen saturation < 90% influenced AA and MPA sizes. In those patients without comorbidities, oxygen desaturation index and minimum oxygen saturation were moderately correlated with both AA and DTA sizes. Participants without comorbidities with oxygen desaturation index > 30 or minimum oxygen saturation < 81% had greater AA and DTA dimensions.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  ascending aorta; computed tomography; descending aorta; dilation; main pulmonary artery; size

Mesh:

Substances:

Year:  2021        PMID: 32876043      PMCID: PMC7849640          DOI: 10.5664/jcsm.8770

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  36 in total

Review 1.  International classification of sleep disorders-third edition: highlights and modifications.

Authors:  Michael J Sateia
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

2.  Obstructive sleep apnoea and its association with left ventricular function and aortic root parameters in newly diagnosed, untreated patients: a prospective study.

Authors:  D Cicek; H Lakadamyali; B D Yağbasan; I Sapmaz; H Müderrisoğlu
Journal:  J Int Med Res       Date:  2011       Impact factor: 1.671

3.  Obstructive sleep apnea is associated with greater thoracic aortic size.

Authors:  Naoki Serizawa; Dai Yumino; Atsushi Takagi; Keiko Gomita; Katsuya Kajimoto; Yukio Tsurumi; Nobuhisa Hagiwara
Journal:  J Am Coll Cardiol       Date:  2008-09-02       Impact factor: 24.094

4.  Early intermittent hypoxia induces proatherogenic changes in aortic wall macrophages in a murine model of obstructive sleep apnea.

Authors:  Alex Gileles-Hillel; Isaac Almendros; Abdelnaby Khalyfa; Shelley X Zhang; Yang Wang; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

Review 5.  Significance of main pulmonary artery dilation on imaging studies.

Authors:  Timothy E Raymond; Joseph E Khabbaza; Ruchi Yadav; Adriano R Tonelli
Journal:  Ann Am Thorac Soc       Date:  2014-12

6.  Prolonged Exposures to Intermittent Hypoxia Promote Visceral White Adipose Tissue Inflammation in a Murine Model of Severe Sleep Apnea: Effect of Normoxic Recovery.

Authors:  Alex Gileles-Hillel; Isaac Almendros; Abdelnaby Khalyfa; Recep Nigdelioglu; Zhuanhong Qiao; Robert B Hamanaka; Gökhan M Mutlu; Mahzad Akbarpour; David Gozal
Journal:  Sleep       Date:  2017-03-01       Impact factor: 5.849

7.  The relative impact of obstructive sleep apnea and hypertension on the structural and functional changes of the thoracic aorta.

Authors:  Li-Ching Lee; Maria Consolacion Torres; See-Meng Khoo; Eric Y Chong; Cindy Lau; Yemon Than; Dong-Xia Shi; Anand Kailasam; Kian-Keong Poh; Chi-Hang Lee; Tiong-Cheng Yeo
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

Review 8.  Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines.

Authors:  Charles W Atwood; Douglas McCrory; Joe G N Garcia; Steven H Abman; Gregory S Ahearn
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

9.  Influence and predicting variables of obstructive sleep apnea on cardiac function and remodeling in patients without congestive heart failure.

Authors:  Yung-Lung Chen; Mao-Chang Su; Wen-Hao Liu; Chin-Chou Wang; Meng-Chih Lin; Mien-Cheng Chen
Journal:  J Clin Sleep Med       Date:  2014-01-15       Impact factor: 4.062

10.  Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome.

Authors:  Omar A Minai; Basma Ricaurte; Roop Kaw; Jeff Hammel; Mary Mansour; Kevin McCarthy; Joseph A Golish; James K Stoller
Journal:  Am J Cardiol       Date:  2009-11-01       Impact factor: 2.778

View more
  2 in total

1.  Obstructive sleep apnea in patients with acute aortic dissection.

Authors:  Evan J Friend; Pavel Leinveber; Marek Orban; John Hochhold; Anna Svatikova; Virend K Somers; Gregg S Pressman
Journal:  Clin Cardiol       Date:  2022-02-23       Impact factor: 3.287

2.  Sleep apnea predicts cardiovascular death in patients with Marfan syndrome: a cohort study.

Authors:  Nele Gessler; Peter Wohlmuth; Omar Anwar; Eike Sebastian Debus; Christian Eickholt; Melanie A Gunawardene; Samer Hakmi; Kathrin Heitmann; Meike Rybczynski; Helke Schueler; Sara Sheikhzadeh; Eike Tigges; Gunther H Wiest; Stephan Willems; Ekaterina Adam; Yskert von Kodolitsch
Journal:  EPMA J       Date:  2022-07-29       Impact factor: 8.836

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.